China Jo-Jo Drugstores Holdings Inc
NASDAQ:CJJD
Balance Sheet
Balance Sheet Decomposition
China Jo-Jo Drugstores Holdings Inc
China Jo-Jo Drugstores Holdings Inc
Balance Sheet
China Jo-Jo Drugstores Holdings Inc
| Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
4
|
7
|
18
|
15
|
9
|
16
|
22
|
18
|
19
|
20
|
|
| Cash |
4
|
7
|
18
|
15
|
9
|
16
|
22
|
18
|
19
|
20
|
|
| Short-Term Investments |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
11
|
9
|
11
|
12
|
13
|
15
|
19
|
23
|
17
|
19
|
|
| Accounts Receivables |
9
|
8
|
9
|
8
|
9
|
10
|
13
|
17
|
14
|
16
|
|
| Other Receivables |
1
|
1
|
3
|
3
|
5
|
5
|
5
|
6
|
3
|
3
|
|
| Inventory |
11
|
11
|
10
|
13
|
14
|
12
|
17
|
16
|
15
|
16
|
|
| Other Current Assets |
16
|
19
|
17
|
22
|
19
|
18
|
15
|
18
|
14
|
14
|
|
| Total Current Assets |
42
|
47
|
56
|
62
|
56
|
61
|
72
|
75
|
64
|
70
|
|
| PP&E Net |
9
|
7
|
5
|
4
|
10
|
30
|
24
|
20
|
20
|
19
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
30
|
24
|
20
|
20
|
19
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
17
|
19
|
21
|
14
|
14
|
|
| Intangible Assets |
3
|
3
|
3
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
3
|
4
|
4
|
2
|
1
|
|
| Other Long-Term Assets |
5
|
5
|
3
|
4
|
3
|
2
|
2
|
2
|
1
|
1
|
|
| Total Assets |
60
N/A
|
62
+4%
|
67
+8%
|
74
+10%
|
73
-1%
|
100
+37%
|
106
+7%
|
106
+0%
|
91
-14%
|
95
+4%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
16
|
17
|
19
|
25
|
23
|
22
|
30
|
27
|
27
|
32
|
|
| Accrued Liabilities |
1
|
1
|
1
|
1
|
1
|
2
|
1
|
4
|
6
|
5
|
|
| Short-Term Debt |
16
|
18
|
13
|
19
|
26
|
28
|
26
|
34
|
29
|
32
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
2
|
3
|
2
|
0
|
0
|
|
| Other Current Liabilities |
10
|
7
|
7
|
10
|
5
|
4
|
5
|
7
|
4
|
6
|
|
| Total Current Liabilities |
42
|
42
|
40
|
55
|
55
|
57
|
65
|
74
|
67
|
74
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
4
|
2
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
1
|
2
|
1
|
1
|
1
|
1
|
|
| Other Liabilities |
0
|
1
|
0
|
0
|
1
|
19
|
15
|
9
|
8
|
6
|
|
| Total Liabilities |
42
N/A
|
43
+1%
|
41
-5%
|
55
+36%
|
55
-1%
|
79
+45%
|
81
+2%
|
82
+2%
|
73
-11%
|
79
+9%
|
|
| Equity | |||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
6
|
6
|
11
|
28
|
29
|
35
|
44
|
47
|
68
|
72
|
|
| Additional Paid In Capital |
19
|
22
|
37
|
44
|
45
|
54
|
67
|
67
|
84
|
86
|
|
| Other Equity |
4
|
3
|
1
|
4
|
3
|
1
|
3
|
4
|
2
|
1
|
|
| Total Equity |
17
N/A
|
19
+12%
|
27
+38%
|
19
-29%
|
18
-4%
|
21
+13%
|
26
+25%
|
24
-6%
|
18
-25%
|
16
-13%
|
|
| Total Liabilities & Equity |
60
N/A
|
62
+4%
|
67
+8%
|
74
+10%
|
73
-1%
|
100
+37%
|
106
+7%
|
106
+0%
|
91
-14%
|
95
+4%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
|